Report : South & Central America Hydrocephalus Shunts Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Age Group (Pediatric and Adults), Type (Ventriculo-Peritoneal, Ventriculo-Atrial, Ventriculo-Pleural, and Lumbo-Peritoneal), Product (Hydrocephalus Valves, Hydrocephalus Catheters, Neuronavigation Systems, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)
At 2.7% CAGR, the South & Central America Hydrocephalus Shunts Market is speculated to be worth US$ 14.09 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the South & Central America hydrocephalus shunts market was valued at US$ 11.99 million in 2022 and is expected to reach US$ 14.09 million by 2028, registering a CAGR of 2.7% from 2022 to 2028. Increasing prevalence of hydrocephalus and increasing advancement in hydrocephalus valves are the critical factors attributed to the market expansion.
Companies in the hydrocephalus shunts market are introducing new advanced programmable valves, shunts based on the latest technologies, and anti-siphon devices, among others. Thus, the launch of such advanced programmable valves is boosting the demand for advanced programmable valves and driving the market growth.
On the contrary, high cost of treatment due to shunts and revision surgeries hampers South & Central America hydrocephalus shunts market.
Based on age group, the market is segmented into pediatric and adults. The pediatric segment held 56.5% market share in 2022, amassing US$ 6.77 million. It is projected to garner US$ 8.01 million by 2028 to expand at 2.8% CAGR during 2022–2028.
Based on type, the market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment held 45.5% market share in 2022, amassing US$ 5.45 million. It is projected to garner US$ 6.53 million by 2028 to expand at 3.0% CAGR during 2022–2028.
Based on product, the market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment held 61.0% market share in 2022, amassing US$ 7.32 million. It is projected to garner US$ 8.71 million by 2028 to expand at 2.9% CAGR during 2022–2028.
Based on end user, the market is segmented into hospitals, ambulatory surgical centers, others. The hospital segment held 56.6% market share in 2022, amassing US$ 6.79 million. It is projected to garner US$ 8.17 million by 2028 to expand at 3.1% CAGR during 2022–2028.
Based on country, the South & Central America hydrocephalus shunts market has been categorized into Brazil, Argentina, and Rest of South & Central America. Our regional analysis states that Brazil captured 71.4% market share in 2022. It was assessed at US$ 8.57 million in 2022 and is likely to hit US$ 10.19 million by 2028, exhibiting a CAGR of 2.9% during the forecast period.
Key players dominating the South & Central America hydrocephalus shunts market are B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); HpBio Próteses, inc.; Medtronic; Natus Medical Incorporated; and Spiegelberg GmbH & Co. KG, among others.
- In July,2019; Integra LifeSciences announced the acquisition of Arkis Biosciences Inc. a privately-held company that offers a portfolio of neurosurgical devices such as catheters. The acquisition of Arkis Biosciences strengthened Integra’s offerings in neurocritical care and Integra’s position as the world leader in advanced catheter technology.
- In May,2020; Aesculap, Inc. in partnership with The Christoph Miethke GmbH & Co. KG (MIETHKE) announced the launch of the M.blue valve in the US. The M.blue valve features advanced gravitational technology, which is incorporated with a fixed differential pressure unit in one valve. It helps to provide a simple and position-dependent solution.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com